CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 11 No. 2
The Love/Vogel Article Reviewed 

Breast Cancer Prevention Strategies

By

Ernst L. Wynder, MD, American Health Foundation, New York

| February 1, 1996

In this issue, Love and Vogel bring attention to the fact that most breast cancers are not inherited but are the result of several, varied hormonal influences. This is an important message because prevention of breast cancer for some women can be accomplished by hormone manipulation from moderate exercise, maintaining low body mass, abstention from alcohol(Drug information on alcohol), and lactation. The authors discuss the physiologic role of delayed pregnancy but avoid the issue in terms of preventive strategy. Many women choose to delay pregnancy in pursuit of career development for economic reasons. This makes for a difficult choice in terms of breast cancer risk, but one that should be addressed. The article proposes that lobular maturation and exposure of the breast to hormones are two key processes in breast cancer. Indeed, emerging data also suggest that excess hormonal exposure in utero may influence adult breast cancer risk.

Although dietary intake is mentioned as one possible means for breast cancer prevention, its effects are understated. Epidemiologists search for the reasons behind extreme variations in the incidence and mortality of disease--an endeavor that is likely to tell us more about etiologic factors than would small differences. With regard to breast cancer, while we and others have researched and written about such risk factors as age at menarche and menopause, parity and age at first pregnancy, weight and alcohol consumption, physical activity and heredity, estrogen supplements and radiation, it would seem clear that none of these variables, either singly or taken together, can account for the major differences in incidence and death rates that exist between Japan and the United States (Figure 1).[1,2]

These differences are particularly striking in postmenopausal women, and can best be explained by dietary intake, as seen in Table 1, which charts food consumption data from 1951 through 1985. The low intake of meat and dairy products among the Japanese is especially noteworthy. Initially, it was thought that perhaps the lower rates of breast cancer in the Japanese are due to genetic differences. However, the fact that, among Japanese women who move to Hawaii, breast cancer rates by the second generation approach those seen in US women indicates that environmental factors, such as diet, play a determining etiologic role.

With respect to weight, premenopausal breast cancer is associated with low body weight, whereas postmenopausal women with breast cancer tend to be somewhat, but not excessively, overweight.

Fatty Acids and Breast Cancer Progression

The concept that diet is an important factor is supported by large-scale animal studies demonstrating that certain types of fatty acids significantly affect the promotion and progression of breast cancer. The diets given in these studies are isocaloric, so that the findings cannot be due to excess calories. Furthermore, mechanistic studies provide biologic validity for the link between nutrition and breast cancer that has been observed in both animal and human studies.

Nutritional assessment studies, both cohort and case-control, have yielded mixed results, which is not unexpected. First, when we compare breast cancer patients with controls, it needs to be recognized that the control patients have a relatively high fat diet as well. Also, because of inherent problems, such as reporting and recall biases associated with nutritional assessments, whether they are based on food frequency questionnaires, 24-hour dietary recall, or 4-day dietary records, dietary histories need to be viewed with caution.

Women's Intervention Nutrition Study

In view of these data, we are currently conducting the Women's Intervention Nutrition Study in postmenopausal stage I and II breast cancer patients treat-ed in standard fashion with either tamoxifen(Drug information on tamoxifen) (Nolvadex) or chemotherapy. This trial, being conducted at approximately 30 cancer centers, is investigating whether a low-fat diet (15% of total calories) can affect the recurrence rate of breast cancer, as compared with a diet in which 30% of calories come from fat. Among the 2,500 patients required for the study, approximately 900 patients have been accrued, and significant differences have already been seen in fat intake between years 1 and 2 in patients vs controls. In the case of large groups with marked dietary differences, 24-hour recall appears to be an adequate nutritional assessment. Furthermore, these data are also being confirmed by an assay of serum fatty acids as dietary biomarkers in women participating in the study.

This trial is based not only on epidemiologic and animal studies but also on the finding that survival among postmenopausal breast cancer patients treated with tamoxifen is twice as high among women in Japan as in Western countries.[3] Recently, Boyd et al have shown that breast duct density, as measured by mammography, is positively affected by a low-fat diet.[4] It is believed that a dense ductal pattern is associated with an elevated risk for breast cancer.

Summary

In summary, we believe that dietary fats, especially saturated and unsaturated fats rich in omega-6 fatty acids, although not fish oils or monounsaturated fats, significantly affect the promotion and progression of breast cancer. We suggest to our colleagues in oncology and those engaged in laboratory studies to pursue these leads in both experimental and clinical settings.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.



Richard R. Love, MD and Victor G. Vogel, MD


1. Kakizoe T (ed): Figures on Cancer in Japan. Tokyo, Japan, Foundation for Promotion of Cancer Research, 1995.

2. Ries LAG, Miller BA, Hankey BF, et al (eds): SEER Cancer Statistics Review, 1973-1991: Tables and Graphs. Bethesda, Maryland, National Cancer Institute, NIH publication no. 94-2789, 1994.

3. Wynder EL, Kajitani T, Kuno J, et al: A comparison of survival rates between American and Japanese patients with breast cancer. Gynecol Obstet 111:196-200, 1963.

4. Boyd NF, Greenberg C, Lockwood G, et al: The effects at 2 years of a low-fat high-carbohydrate diet on radiological features of the breast: Results from a randomized trial (poster abstract 6). Dietary Fat and Cancer: Genetic and Molecular Interactions. Washington, DC, American Institute For Cancer Research 1996 Research Conference poster abstract booklet.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • A 49-Year-Old Woman Develops Thickened and Bound-Down Skin
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy